Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel after peripheral arterial stenting in PAD patients with high platelet reactivity
2014-001989-97Phase 3Terminated
- Sponsor
- OA Doz. Dr. Thomas Müller c/o B&S Zentrallabor Konventhospital Barmherzige Brüder Linz
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ticagrelor and clopidogrel in arteriosclerosis obliterans (2 arms), sponsored by OA Doz. Dr. Thomas Müller c/o B&S Zentrallabor Konventhospital Barmherzige Brüder Linz. Started Jun 2014; status: terminated.
02
Drugs
ticagrelorclopidogrel
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on 2014-001989-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001989-97.